| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Laboratory of Experimental Medicine (D.L.E., A.K.C., M.C.), Université Libre de Bruxelles, Division of Endocrinology (M.C.), Erasmus Hospital, Brussels, Belgium
* To whom correspondence should be addressed. E-mail: deizirik{at}ulb.ac.be.
Accumulating evidence suggests that endoplasmic reticulum (ER) stress plays a role in the pathogenesis of diabetes, contributing to pancreatic
-cell loss and insulin resistance. Components of the unfolded protein response (UPR) play a dual role in
-cells, acting as beneficial regulators under physiological conditions or as triggers of
-cell dysfunction and apoptosis under situations of chronic stress. Novel findings suggest that "what makes a
-cell a
-cell", i.e., its enormous capacity to synthesize and secrete insulin, is also its "Achilles heel", rendering it vulnerable to chronic high glucose and fatty acid exposure, agents that contribute to
-cell failure in type 2 diabetes. In this review, we address the transition from physiology to pathology, namely how and why the physiological UPR evolves to a proapoptotic ER stress response and which are the defenses triggered by
-cells against these challenges. ER stress may also link obesity and insulin resistance in type 2 diabetes. High-fat feeding and obesity induce ER stress in liver, which suppresses insulin signaling via JNK activation. In vitro data suggest that ER stress may also contribute to cytokine-induced
-cell death. Thus, the cytokines IL-1
and IFN-
, putative mediators of
-cell loss in type 1 diabetes, induce severe ER stress through, respectively, NO-mediated depletion of ER calcium and inhibition of ER chaperones, thus hampering
-cell defenses and amplifying the proapoptotic pathways. A better understanding of the pathways regulating ER stress in
-cells may be instrumental for the design of novel therapies to prevent
-cell loss in diabetes.
This article has been cited by other articles:
![]() |
J. A. Corbett Thioredoxin-Interacting Protein Is Killing My {beta}-cells! Diabetes, April 1, 2008; 57(4): 797 - 798. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |